RIV.TO - Canopy Rivers Inc.
| Previous Close | 0.8400 |
| Open | 0.8400 |
| Bid | 0.8100 x N/A |
| Ask | 0.8300 x N/A |
| Day's Range | 0.8100 - 0.8700 |
| 52 Week Range | 0.5400 - 4.6700 |
| Volume | 21,067 |
| Avg. Volume | 238,147 |
| Market Cap | 156.971M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0670 |
| Earnings Date | Feb. 13, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.69 |
CNW GroupCanopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth
Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth
CNW GroupCanopy Rivers' Pharmhouse Joint Venture Receives Milestone Licence Amendment
TORONTO , March 2, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario , received a licence amendment from Health Canada allowing for cultivation across its entire greenhouse, which is now fully operational. PharmHouse plans to immediately ramp up production in accordance with its offtake agreements with Canopy Growth Corporation and TerrAscend Canada Inc. PharmHouse has committed 50% of its 2020 output pursuant to these agreements, and currently expects to use the remaining 50% of its capacity for both additional offtake agreements and its own private label brand. "The receipt of our licence amendment represents a large milestone for PharmHouse," said Tony Abbas , General Manager, PharmHouse.
CNW GroupRivers Rundown: Canopy Rivers' Portfolio Companies Expanding Canadian Retail Presence
Canopy Rivers published new investor presentation and provides update on Headset, YSS, and JWC TORONTO , Feb. 27, 2020 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers ") (TSX: RIV, OTC: CNPOF), a ...
- The Canadian Press
Canopy Rivers swings to loss, withdraws guidance on industry headwinds
TORONTO — Canopy Rivers Inc. says it swung to a loss in its third quarter of 2020 and has withdrawn its full-year guidance over multiple headwinds in the cannabis industry.The venture capital arm of Canopy Growth says it had a net loss of $2.7 million, or one cent per share, for the three months ending Dec. 31, compared with a net income of $1.4 million, or one cent per share, a year earlier.Analysts had expected a net loss of two cents per share, according to financial markets data firm Refinitiv.Canopy Rivers says it has withdrawn its full year guidance because uncertainty created in the industry from unanticipated licensing delays, "reformed views" on the ramp-up time for large-scale cannabis greenhouses, and a general decline in wholesale cannabis prices.The firm, which holds investments in numerous cannabis firms, had previously expected earnings before deductions of between $85 million and $100 million from its PharmaHouse and Vert Mirabel holdings.Canada's cannabis industry has struggled to reach profitability since legalization of marijuana products and companies have turned to cost cutting measures.This report by The Canadian Press was first published Feb. 14, 2020.Companies in this story: (TSX:RIV) The Canadian PressNote to readers: This is a corrected story. A previous version contained incorrect income and earnings per share figures.
CNW GroupCanopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
TORONTO , Feb. 14, 2020 /CNW/ - Canopy Rivers Inc. (the " Company " or " Canopy Rivers ") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its ...
CNW GroupCanopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment
TORONTO, Feb. 7, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that Canopy Rivers Corporation ("Canopy Rivers") subscribed for 2,380,952 units (each a "Unit") of James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) at a price of $0.21 per Unit for total consideration of approximately $500,000 in connection with JWC's non-brokered private placement financing (the "Offering"). Each Unit is comprised of one common share in the capital of JWC (each a "Common Share") and one-half of one Common Share purchase warrant (each full warrant, a "Warrant").
CNW GroupRivers Rundown: Canopy Rivers' CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint
TORONTO , Feb. 6, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and its portfolio companies have made a series of recent announcements that include a board appointment for Canopy Rivers' President & CEO, one brand's retail launch in Canada , and a founder and portfolio company receiving awards for their accomplishments. Other Canopy Rivers portfolio companies hit the milestones required to help further expand and build out their facilities.
- CNW Group
TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies
TORONTO, Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada, and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.
CNW GroupCanopy Rivers Amends Terms of Loan to TerrAscend Canada
TORONTO, Feb. 5, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that as of February 4, 2020 Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of CRI, has amended the terms of its recent US$10 million loan (the "Loan") to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly‑owned subsidiary of TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The Loan, announced October 2, 2019, included the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of C$1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of TerrAscend allowing for the purchase of common shares of TerrAscend (the "Common Shares") (the "Original Warrants") with an exercise price of C$6.49.
CNW GroupCanopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
TORONTO , Jan. 24, 2020 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its third ...
CNW GroupRivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations
TORONTO , Jan. 17, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies have made a series of recent announcements relating to their plans for the cannabis retail market or U.S. cannabis operations. Two portfolio companies are evaluating opportunities to expand their retail footprint in Canada , while another will remember 2019 as the year it grew its retail presence across the U.S., Canada , and Europe . Another Canopy Rivers portfolio company is taking steps to build out its U.S. operations, as more states look to legalize medical or recreational cannabis.
- Yahoo Finance Canada
115 cannabis drink companies are taking aim at booze and soda
Beer, wine and spirit giants and small startups alike are betting on cannabis beverages disrupting the drinks market with products that can soothe sore muscles after a workout, or deliver a hangover-free buzz.
CNW GroupCanopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant
TORONTO, Jan. 8, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply its proprietary ultraviolet ("UV") light technology to medical cannabis. While BioLumic's approach has been successful in increasing yields in certain crops, such as strawberries, by up to 60%, this approval marks the first time the company's UV light technology will be used on cannabis.
- CNW Group
Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note
TORONTO , Dec. 12, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, portfolio companies made several announcements that demonstrate the portfolio's continued growth heading into 2020. Among others, this includes new features from a business intelligence and analytics software platform, a licensed producer responding to consumer demands for high-THC products with the launch of four new cannabis strains, and a portfolio company expanding its retail footprint. Headset, Inc. ("Headset") launched the Demand Planning add-on to help its customers understand the "when" of the retail cannabis industry.
